(Q38387210)

2 September 2017

New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine (English)

1 reference

2 September 2017

0 references

visceral leishmaniasis

1 reference

1 reference

Michel Vaillant

6

0 references

Shyam Sundar

1

object named as

Shyam Sundar

1 reference

2 September 2017

7

Piero Olliaro

1 reference

2 September 2017

M Rai

2

1 reference

2 September 2017

J Chakravarty

3

1 reference

2 September 2017

D Agarwal

4

1 reference

2 September 2017

N Agrawal

5

1 reference

2 September 2017

Henry W Murray

8

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 October 2008

1 reference

Clinical Infectious Diseases

2 September 2017

1 reference

2 September 2017

47

1 reference

2 September 2017

8

1 reference

2 September 2017

1000-1006

1 reference

Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic

2 September 2017

1 reference

Advances in leishmaniasis

21 January 2018

1 reference

Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004

21 January 2018

1 reference

Oral miltefosine for Indian visceral leishmaniasis

21 January 2018

1 reference

Injectable paromomycin for Visceral leishmaniasis in India

21 January 2018

1 reference

Treatment of visceral leishmaniasis in Kenya by aminosidine alone or combined with sodium stibogluconate

21 January 2018

1 reference

Epidemic visceral leishmaniasis in Sudan: a randomized trial of aminosidine plus sodium stibogluconate versus sodium stibogluconate alone

21 January 2018

1 reference

Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda

21 January 2018

1 reference

Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial

21 January 2018

1 reference

Single-dose liposomal amphotericin B in the treatment of visceral leishmaniasis in India: a multicenter study

21 January 2018

1 reference

Amphotericin B treatment for Indian visceral leishmaniasis: response to 15 daily versus alternate-day infusions

21 January 2018

1 reference

Progress in the treatment of a neglected infectious disease: visceral leishmaniasis

21 January 2018

1 reference

Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/591972

1 reference

2 September 2017

1 reference